Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Bone disease and management of myeloma complications
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Bone disease and management of myeloma complications ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
3 Mar 2017
Monoclonal antibodies in multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Monoclonal antibodies in multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
2 Mar 2017
Treatment options for newly diagnosed multiple myeloma and management of bone...
Prof Sonneveld, Prof Cavo, Prof Terpos and Professor Voorhees
Treatment options for newly diagnosed multiple myeloma and management of bone disease: Roundtable at IMW 2017 ( Prof Sonneveld, Prof Cavo, Prof Terpos and Professor Voorhees )
2 Mar 2017
Promising myeloma agents in phase II trials
Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical...
Promising myeloma agents in phase II trials ( Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical Center, New York, USA )
2 Mar 2017
Ongoing transplant phase III trials for myeloma
Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA
Ongoing transplant phase III trials for myeloma ( Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA )
2 Mar 2017
Post autologous transplant therapies in high risk multiple myeloma: StaMINA...
Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA
Post autologous transplant therapies in high risk multiple myeloma: StaMINA trial update ( Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA )
2 Mar 2017
Updates from ASPIRE and ENDEAVOR: Multicenter phase III studies of carfilzomib...
Dr David Siegel - John Theurer Cancer Center, Hackensack, USA
Updates from ASPIRE and ENDEAVOR: Multicenter phase III studies of carfilzomib for relapsed/refractory multiple myeloma ( Dr David Siegel - John Theurer Cancer Center, Hackensack, USA )
2 Mar 2017
Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple...
Dr David Siegel - John Theurer Cancer Center, Hackensack, USA
Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma ( Dr David Siegel - John Theurer Cancer Center, Hackensack, USA )
2 Mar 2017
How should we treat smoldering multiple myeloma? Expert discussion from IMW 2017
Prof Maria-Victoria Mateos, Prof Paul Richardson
How should we treat smoldering multiple myeloma? Expert discussion from IMW 2017 ( Prof Maria-Victoria Mateos, Prof Paul Richardson )
2 Mar 2017
Examining strategies to tailor multiple myeloma immunotherapy
Dr Jeffrey Zonder - Karmanos Cancer Institute, Detroit, USA
Examining strategies to tailor multiple myeloma immunotherapy ( Dr Jeffrey Zonder - Karmanos Cancer Institute, Detroit, USA )
2 Mar 2017
Sequencing multiple myeloma using blood tests
Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA
Sequencing multiple myeloma using blood tests ( Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA )
2 Mar 2017
HARMONY project: An overview
Dr Jesus Hernandez - Universidad de Salamanca, Salamanca, Spain
HARMONY project: An overview ( Dr Jesus Hernandez - Universidad de Salamanca, Salamanca, Spain )
14 Feb 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation